Related Experiment Video
Updated: Feb 2, 2026

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
Published on: September 2, 2014
SBF-1 preferentially inhibits growth of highly malignant human liposarcoma cells
Wei Chen1, Xuelong Qian1, Yue Hu1
1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing 210023, China.
Abstract:
Frequent local recurrence and metastasis are generally involved in human liposarcoma, but the management is a challenge. There is an urgent need for improved effective therapy. In the present study, we reported that SBF-1, a steroidal glycoside, inhibited the growth of cultured highly malignant human liposarcoma SW872-S cells in vitro and in vivo. SBF-1 down-regulated the phosphorylation of protein kinase B (AKT) and thus reduced cell adhesion to fibronectin and laminin. Then we found that SBF-1 inhibited the expression of oxysterol binding protein (OSBP) in SW872-S cells, indicating that OSBP may be involved in malignant liposarcoma cell survival. Cancer cell growth and AKT phosphorylation were inhibited significantly upon knockdown of OSBP in SW872-S cells in vitro. Taken together, these results suggest that SBF-1 causes an apparent loss of OSBP function in SW872-S cells, resulting in growth inhibition. Based on our findings, OSBP serves as a potential therapeutic target for human liposarcoma.
Insights
A steroidal glycoside, SBF-1, effectively inhibits human liposarcoma growth by targeting oxysterol binding protein (OSBP). This discovery offers a potential new therapeutic strategy for liposarcoma, addressing challenges in managing this cancer.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Liposarcoma frequently recurs and metastasizes, posing significant management challenges.
- There is a critical need for novel and effective therapeutic strategies for liposarcoma.
- Current treatments are limited by challenges in managing local recurrence and metastasis.
Purpose of the Study:
- To investigate the anti-cancer effects of SBF-1, a steroidal glycoside, on human liposarcoma cells.
- To elucidate the molecular mechanisms underlying SBF-1's inhibitory action on liposarcoma growth.
- To identify potential therapeutic targets for liposarcoma treatment.
Main Methods:
- In vitro and in vivo studies using human liposarcoma SW872-S cells.
- Analysis of protein kinase B (AKT) phosphorylation and cell adhesion.
- Investigation of oxysterol binding protein (OSBP) expression and function.
- Gene knockdown experiments to assess OSBP's role in cell survival and growth.
Main Results:
- SBF-1 significantly inhibited the growth of liposarcoma cells in vitro and in vivo.
- SBF-1 down-regulated AKT phosphorylation, reducing cell adhesion to fibronectin and laminin.
- SBF-1 inhibited OSBP expression, suggesting its involvement in liposarcoma cell survival.
- Knockdown of OSBP mimicked SBF-1's effects, inhibiting cell growth and AKT phosphorylation.
Conclusions:
- SBF-1 exerts anti-cancer effects by disrupting OSBP function in liposarcoma cells.
- OSBP plays a crucial role in the survival and proliferation of malignant liposarcoma cells.
- OSBP represents a promising therapeutic target for human liposarcoma.
Related Concept Videos
Feedback Inhibition
Enzyme Inhibition
Cells Coordinate Growth and Proliferation
Primary and Secondary Growth in Roots and Shoots
Population Growth
Meristems and Plant Growth

